HKEX:719 Short term 20 days. Potential profit 16%HKEX:719 has a head and shoulder pattern. The target is near the previous resistance.
Buy in @3.94
Cut loss @3.68
Target @4.58
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.67 HKD
509.61 M HKD
9.11 B HKD
174.46 M
About Shandong Xinhua Pharmaceutical Company Limited Class A
Sector
Industry
CEO
Wen Hui Xu
Website
Headquarters
Zibo
Founded
1943
ISIN
CNE100000411
FIGI
BBG000BD34Z8
Shandong Xinhua Pharmaceutical Co., Ltd. engages in the development, production and sales of pharmaceutical and synthetic chemical products. It operates the business through the following segments: Bulk Pharmaceuticals, Preparations, Chemical and Other Products. The firm's products include analgin, caffeine, amidopyrine, ibuprofen, theophylline, aspirin, hydrocortisone and pipemidic acid. The company also sells pharmaceutical raw materials, preprations, antibiotic preparations, herbal medicine, biological products, medical appliances, chinese medicines and beauty products. Shandong Xinhua Pharmaceutical was founded in 1943 and is headquartered in Zibo, China.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 719 is 7.61 HKD — it has decreased by −2.97% in the past 24 hours. Watch Shandong Xinhua Pharmaceutical Company Limited Class H stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange Shandong Xinhua Pharmaceutical Company Limited Class H stocks are traded under the ticker 719.
719 stock has fallen by −5.17% compared to the previous week, the month change is a −7.39% fall, over the last year Shandong Xinhua Pharmaceutical Company Limited Class H has showed a 43.58% increase.
We've gathered analysts' opinions on Shandong Xinhua Pharmaceutical Company Limited Class H future price: according to them, 719 price has a max estimate of 12.03 HKD and a min estimate of 12.03 HKD. Watch 719 chart and read a more detailed Shandong Xinhua Pharmaceutical Company Limited Class H stock forecast: see what analysts think of Shandong Xinhua Pharmaceutical Company Limited Class H and suggest that you do with its stocks.
719 stock is 3.64% volatile and has beta coefficient of 0.70. Track Shandong Xinhua Pharmaceutical Company Limited Class H stock price on the chart and check out the list of the most volatile stocks — is Shandong Xinhua Pharmaceutical Company Limited Class H there?
Today Shandong Xinhua Pharmaceutical Company Limited Class H has the market capitalization of 5.28 B, it has decreased by −3.55% over the last week.
Yes, you can track Shandong Xinhua Pharmaceutical Company Limited Class H financials in yearly and quarterly reports right on TradingView.
Shandong Xinhua Pharmaceutical Company Limited Class H is going to release the next earnings report on Oct 23, 2025. Keep track of upcoming events with our Earnings Calendar.
719 earnings for the last quarter are 0.19 HKD per share, whereas the estimation was 0.19 HKD resulting in a 0.00% surprise. The estimated earnings for the next quarter are 0.12 HKD per share. See more details about Shandong Xinhua Pharmaceutical Company Limited Class H earnings.
719 net income for the last quarter is 120.49 M HKD, while the quarter before that showed 119.85 M HKD of net income which accounts for 0.54% change. Track more Shandong Xinhua Pharmaceutical Company Limited Class H financial stats to get the full picture.
Shandong Xinhua Pharmaceutical Company Limited Class H dividend yield was 5.17% in 2024, and payout ratio reached 40.16%. The year before the numbers were 4.74% and 33.52% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Shandong Xinhua Pharmaceutical Company Limited Class H EBITDA is 1.10 B HKD, and current EBITDA margin is 12.57%. See more stats in Shandong Xinhua Pharmaceutical Company Limited Class H financial statements.
Like other stocks, 719 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Shandong Xinhua Pharmaceutical Company Limited Class H stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Shandong Xinhua Pharmaceutical Company Limited Class H technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Shandong Xinhua Pharmaceutical Company Limited Class H stock shows the buy signal. See more of Shandong Xinhua Pharmaceutical Company Limited Class H technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.